This is the authors' abstract. We don't add key points for this paper.
This cross-sectional study examines the relative association of US Inflation Reduction Act (IRA) provisions with out-of-pocket costs for specialty drugs for Medicare Part D beneficiaries.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Doshi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: